Susquehanna International Group, LLP Vaxart, Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Vaxart, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 120,702 shares of VXRT stock, worth $48,280. This represents 0.0% of its overall portfolio holdings.

Number of Shares

120,702

Previous 328,797 63.29%

Holding current value

$48,280

Previous $217,000 77.42%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$0.41 - $0.94 $85,318 - $195,609	-208,095 Reduced 63.29%	120,702 $49,000
Q4 2024 Feb 14, 2025	BUY	$0.54 - $0.86 $37,387 - $59,543	69,237 Added 26.67%	328,797 $217,000
Q3 2024 Nov 14, 2024	SELL	$0.58 - $0.99 $53,451 - $91,235	-92,157 Reduced 26.2%	259,560 $220,000
Q2 2024 Aug 15, 2024	BUY	$0.53 - $1.3 $73,642 - $180,633	138,949 Added 65.31%	351,717 $235,000
Q1 2024 May 07, 2024	BUY	$0.56 - $1.41 $75,392 - $189,826	134,629 Added 172.29%	212,768 $276,000
Q4 2023 Feb 14, 2024	SELL	$0.57 - $0.85 $17,533 - $26,146	-30,761 Reduced 28.25%	78,139 $44,000
Q3 2023 Nov 14, 2023	SELL	$0.69 - $0.85 $198,313 - $244,299	-287,411 Reduced 72.52%	108,900 $81,000
Q2 2023 Aug 11, 2023	BUY	$0.6 - $1.41 $194,419 - $456,885	324,032 Added 448.31%	396,311 $289,000
Q1 2023 May 16, 2023	SELL	$0.71 - $1.25 $182,700 - $321,655	-257,324 Reduced 78.07%	72,279 $54,000
Q4 2022 Feb 14, 2023	SELL	$0.75 - $2.24 $253,764 - $757,910	-338,353 Reduced 50.65%	329,603 $316,000
Q3 2022 Nov 14, 2022	BUY	$2.09 - $4.5 $576,361 - $1.24 Million	275,771 Added 70.32%	667,956 $1.46 Million
Q2 2022 Aug 15, 2022	SELL	$2.7 - $5.28 $800,560 - $1.57 Million	-296,504 Reduced 43.05%	392,185 $1.37 Million
Q1 2022 May 16, 2022	SELL	$4.29 - $6.64 $1.38 Million - $2.14 Million	-322,532 Reduced 31.9%	688,689 $3.47 Million
Q4 2021 Feb 14, 2022	SELL	$5.77 - $7.96 $987,431 - $1.36 Million	-171,132 Reduced 14.47%	1,011,221 $6.34 Million
Q3 2021 Nov 15, 2021	SELL	$6.67 - $9.8 $2.49 Million - $3.65 Million	-372,887 Reduced 23.98%	1,182,353 $9.4 Million
Q2 2021 Aug 11, 2021	BUY	$5.06 - $10.78 $2.25 Million - $4.79 Million	444,489 Added 40.02%	1,555,240 $11.6 Million
Q1 2021 May 17, 2021	BUY	$5.64 - $23.33 $1.79 Million - $7.42 Million	317,935 Added 40.1%	1,110,751 $6.72 Million
Q4 2020 Feb 16, 2021	BUY	$3.5 - $7.98 $1.68 Million - $3.83 Million	479,707 Added 153.21%	792,816 $4.53 Million
Q3 2020 Nov 16, 2020	BUY	$4.78 - $16.97 $1.5 Million - $5.31 Million	313,109 New	313,109 $2.08 Million
Q2 2020 Aug 14, 2020	SELL	$1.68 - $8.85 $18,046 - $95,066	-10,742 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.34 - $2.87 $3,652 - $30,829	10,742 New	10,742 $19,000
Q1 2019 May 15, 2019	SELL	$1.5 - $2.34 $29,797 - $46,484	-19,865 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.88 - $5.25 $16,923 - $47,260	9,002 Added 82.87%	19,865 $37,000
Q3 2018 Nov 14, 2018	BUY	$2.42 - $3.29 $26,288 - $35,739	10,863 New	10,863 $31,000

Others Institutions Holding VXRT

# of Institutions

101

Shares Held

27.5M

Call Options Held

14.3K

Put Options Held

55.2K

View Full List

About Vaxart, Inc.

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $50.6M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

More about VXRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Vaxart, Inc. Transaction History